Grandfield & Dodd LLC lessened its holdings in Praxair, Inc. (NYSE:PX) by 1.6% in the third quarter, HoldingsChannel.com reports. The firm owned 119,043 shares of the basic materials company’s stock after selling 1,945 shares during the period. Praxair accounts for approximately 2.0% of Grandfield & Dodd LLC’s investment portfolio, making the stock its 13th biggest holding. Grandfield & Dodd LLC’s holdings in Praxair were worth $19,134,000 at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in the business. Cambridge Investment Research Advisors Inc. boosted its holdings in Praxair by 7.8% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 16,114 shares of the basic materials company’s stock worth $2,590,000 after purchasing an additional 1,170 shares during the period. Zions Bancorporation lifted its stake in Praxair by 32.8% in the third quarter. Zions Bancorporation now owns 5,259 shares of the basic materials company’s stock valued at $845,000 after buying an additional 1,298 shares during the last quarter. Commerce Bank lifted its stake in Praxair by 1.9% in the third quarter. Commerce Bank now owns 35,600 shares of the basic materials company’s stock valued at $5,722,000 after buying an additional 677 shares during the last quarter. Wealth Enhancement Advisory Services LLC bought a new stake in Praxair in the third quarter valued at $1,010,000. Finally, Marathon Asset Management LLP lifted its stake in Praxair by 2.5% in the third quarter. Marathon Asset Management LLP now owns 1,169,410 shares of the basic materials company’s stock valued at $187,959,000 after buying an additional 28,059 shares during the last quarter. 86.18% of the stock is owned by hedge funds and other institutional investors.
PX stock opened at $164.50 on Tuesday. Praxair, Inc. has a 1 year low of $140.00 and a 1 year high of $169.75.
A number of equities research analysts have issued reports on PX shares. Citigroup raised their target price on Praxair from $177.00 to $189.00 and gave the company a “buy” rating in a research note on Wednesday, July 11th. BMO Capital Markets reiterated a “hold” rating and issued a $164.00 target price on shares of Praxair in a research note on Tuesday, July 17th. Jefferies Financial Group reiterated a “$165.03” rating and issued a $194.00 target price on shares of Praxair in a research note on Wednesday, July 18th. Zacks Investment Research cut Praxair from a “hold” rating to a “sell” rating in a research note on Thursday, July 19th. Finally, JPMorgan Chase & Co. raised their target price on Praxair from $180.00 to $184.00 and gave the company an “overweight” rating in a research note on Friday, July 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and eight have issued a buy rating to the stock. Praxair currently has a consensus rating of “Buy” and an average target price of $175.38.
COPYRIGHT VIOLATION NOTICE: “Praxair, Inc. (PX) Stake Decreased by Grandfield & Dodd LLC” was first published by Macon Daily and is owned by of Macon Daily. If you are reading this news story on another domain, it was copied illegally and republished in violation of US and international copyright law. The legal version of this news story can be accessed at https://macondaily.com/2018/11/06/praxair-inc-px-stake-decreased-by-grandfield-dodd-llc.html.
Praxair Company Profile
Praxair, Inc produces and distributes industrial gases. It operates through five segments: North America, Europe, South America, Asia, and Surface Technologies. The company offers atmospheric gases, including oxygen, nitrogen, argon, and rare gases; and process gases, such as carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.
Featured Story: What is a capital gain?
Want to see what other hedge funds are holding PX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Praxair, Inc. (NYSE:PX).
Receive News & Ratings for Praxair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Praxair and related companies with MarketBeat.com's FREE daily email newsletter.